X T L Biopharmaceuticals reported $1.3K in Interest Expense on Debt for its fiscal quarter ending in June of 2024.


Interest Expense On Debt Change Date
Alaunos Therapeutics USD 0 0 Dec/2023
Bioline Rx USD 276K 1.35M Jun/2025
Teva Pharmaceutical Industries USD 252M 40M Jun/2025